The nation of Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential information.
This rejection came to light following a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesperson later clarified that the United States was seeking biological samples for research and profit but was unwilling to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to both sides so the nation's vital HIV programme can proceed.
Wider Background
Zimbabwe's decision follows a similar situation in Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.
As per reports, Sixteen nations in Africa have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our people if a future health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to further dialogue with our US partners on how future co-operation might be arranged in a way that honours the sovereignty and interests of both nations."
Health Experts Response
A leading public health body expressed it understood the official position, but urged that talks need to persist since a large portion of the country's HIV programmes were funded by external financing.
"Where technical issues exist, such as those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.
The halted deal highlights the ongoing challenges between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.